Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
Clinical trial NCT04502706 · TERMINATED
Trial details
- NCT number
- NCT04502706
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2022-03-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.